KCM Investment Advisors LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.8% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 10,632 shares of the healthcare conglomerate’s stock after selling 84 shares during the period. KCM Investment Advisors LLC’s holdings in UnitedHealth Group were worth $1,971,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in the stock. Regal Wealth Group Inc. boosted its holdings in UnitedHealth Group by 0.4% in the second quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock valued at $138,000 after acquiring an additional 3 shares in the last quarter. Jackson Grant Investment Advisers Inc. boosted its holdings in UnitedHealth Group by 0.4% in the second quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock valued at $204,000 after acquiring an additional 4 shares in the last quarter. RB Capital Management LLC boosted its holdings in UnitedHealth Group by 0.4% in the second quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock valued at $321,000 after acquiring an additional 7 shares in the last quarter. Altfest L J & Co. Inc. boosted its holdings in UnitedHealth Group by 0.3% in the second quarter. Altfest L J & Co. Inc. now owns 2,963 shares of the healthcare conglomerate’s stock valued at $549,000 after acquiring an additional 10 shares in the last quarter. Finally, Budros Ruhlin & Roe Inc. boosted its holdings in UnitedHealth Group by 0.8% in the first quarter. Budros Ruhlin & Roe Inc. now owns 1,832 shares of the healthcare conglomerate’s stock valued at $301,000 after acquiring an additional 15 shares in the last quarter. Institutional investors and hedge funds own 85.71% of the company’s stock.

UnitedHealth Group Incorporated (NYSE UNH) opened at $212.60 on Wednesday. UnitedHealth Group Incorporated has a 52-week low of $150.00 and a 52-week high of $213.93. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. The firm has a market capitalization of $205,550.00, a PE ratio of 21.86, a price-to-earnings-growth ratio of 1.56 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same quarter in the previous year, the firm earned $2.17 EPS. UnitedHealth Group’s revenue was up 8.7% on a year-over-year basis. equities analysts forecast that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be given a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 1.41%. The ex-dividend date is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is 34.09%.

ILLEGAL ACTIVITY NOTICE: “UnitedHealth Group Incorporated (UNH) Stake Lessened by KCM Investment Advisors LLC” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another domain, it was stolen and republished in violation of U.S. & international trademark & copyright law. The original version of this news story can be read at https://www.thecerbatgem.com/2017/11/22/unitedhealth-group-incorporated-unh-stake-lessened-by-kcm-investment-advisors-llc.html.

Several equities analysts have commented on the company. Jefferies Group LLC reissued a “buy” rating and set a $215.00 price objective on shares of UnitedHealth Group in a research report on Friday, August 18th. Cowen and Company reissued an “outperform” rating and set a $220.00 price objective (up previously from $175.00) on shares of UnitedHealth Group in a research report on Friday, August 11th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 price objective for the company in a research report on Tuesday, August 1st. BMO Capital Markets assumed coverage on UnitedHealth Group in a research report on Monday, October 16th. They set an “outperform” rating and a $250.00 price objective for the company. Finally, Citigroup Inc. raised their price objective on UnitedHealth Group from $213.00 to $235.00 and gave the company a “buy” rating in a research report on Wednesday, October 18th. Three investment analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $216.65.

In other UnitedHealth Group news, insider Thomas E. Roos sold 975 shares of the business’s stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $205.47, for a total transaction of $200,333.25. Following the completion of the sale, the insider now directly owns 24,630 shares in the company, valued at approximately $5,060,726.10. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Larry C. Renfro sold 50,574 shares of the business’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total value of $10,019,215.14. Following the sale, the insider now owns 195,625 shares of the company’s stock, valued at $38,755,268.75. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 57,606 shares of company stock valued at $11,433,133. Corporate insiders own 0.89% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.